Horizons in Assisted Circulation III
In 1985, the Working Group on Mechanical Circulatory Support of the National Heart, Lung, and Blood Institute (NHLBI) reconfirmed that cardiac transplantation, or a potential mechanical analog, continues to be the most effective procedure for treating end-stage heart disease. Furthermore, no new technologies were envisaged by the Working Group for the next 5–15 years that might make the artificial heart obsolete. However, much more research and development must be carried out before we can expect safe and effective mechanical support devices for long-term therapeutic applications.
KeywordsCardiogenic Shock Artificial Heart Mechanical Circulatory Support Replacement Device Assist Circulation
Unable to display preview. Download preview PDF.